课题基金 / 基金详情

项目摘要

项目成果

Nicholas James Leeper的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):本研究的目的是研究apelin-APJ信号传导在血管疾病中的作用。APJ是一种G蛋白偶联受体,与血管紧张素II AI型受体具有31%的同源性。最近鉴定的APJ受体配体apelin是一种有效的循环正性肌力药,具有一氧化氮依赖性血管舒张特性。研究已经确定了apelin-APJ轴的其他假定生理作用,包括液体平衡的中枢调节、血管紧张素途径的拮抗作用和脂肪细胞信号传导。最近,apelin和APJ与心血管疾病状态有关。Apelin在晚期心力衰竭中下调,缺乏APJ受体的动物对血管紧张素II诱导的高血压过敏。相反,apelin输注支持缺血性心肌病模型的收缩性并改善血液动力学参数,并降低自发性高血压大鼠的血压。该蛋白在低流量条件下也下调,在缺氧和氧化应激条件下上调。我们假设apelin-APJ通路也参与血管疾病状态,如动脉粥样硬化和血管重塑。Quertermous实验室已经成功地创建了apelin和APJ基因敲除小鼠,这些突变正在与apoE缺陷背景和其他相关遗传模型交叉,以研究改变的apelin-APJ信号传导对疾病过程的影响。将对动脉粥样硬化形成和血管重塑进行定量分析。阐明爱帕琳调节这些作用的机制的实验将包括炎症标志物产生和内皮细胞活化的特异性分析。此外,一氧化氮的作用将被质疑与NO生产的定量测量。最终,我们的目标是清楚地阐明apelin-APJ系统在血管疾病中的作用,并确定发病机制发生的分子途径。在美国,心血管疾病是发病率、死亡率和卫生保健支出的主要原因。最近发现的apelin-APJ通路与充血性心力衰竭和高血压性心脏病等疾病的发展有关。该系统值得进一步研究,目的是开发新的治疗方法来对抗人类疾病。
英文摘要
DESCRIPTION (provided by applicant): The aim of this study is to investigate the role of apelin-APJ signaling in vascular disease. APJ is a G protein-coupled receptor with 31% homology to the angiotensin II type-AI receptor. The recently identified APJ receptor ligand, apelin, is a potent circulating inotrope and with nitric oxide-dependent vasodilatory properties. Studies have identified other putative physiologic roles for the apelin-APJ axis, including the central regulation of fluid balance, antagonism of the angiotensin pathway, and adipoinsular signaling. More recently, apelin and APJ have been implicated in cardiovascular disease states. Apelin is downregulated in advanced heart failure and animals lacking the APJ receptor are hypersensitive to angiotensin ll-induced hypertension. Conversely, apelin infusion supports contractility and improves hemodynamic parameters in models of ischemic cardiomyopathy, and reduces blood pressure in spontaneously hypertensive rats. The protein is also downregulated in low flow conditions, and is upregulated in settings of hypoxia and oxidative stress. We hypothesize that the apelin-APJ pathway is also involved in vascular disease states such as atherosclerosis and vascular remodeling. The Quertermous laboratory has successfully created apelin and APJ knockout mice, and these mutations are being crossed onto the apoE deficient background and other pertinent genetic models to study the impact of altered apelin-APJ signaling on disease processes. Quantitative analysis of atherogenesis and vascular remodeling will be performed. Experiments to elucidate the mechanism by which apelin modulates these effects will include specific analysis of inflammatory marker production and endothelial cell activation. Furthermore, the role of nitric oxide will be queried with quantitative measurement of NO production. Ultimately, we aim to clearly elucidate the role of the apelin-APJ system in vascular disease, and identify the molecular pathways by which pathogenesis occurs. Cardiovascular disease is a leading cause of morbidity, mortality and health care expenditure in the United States. The recently discovered apelin-APJ pathway is implicated in the development of conditions such as congestive heart failure and hypertensive heart disease. This system warrants further investigation with the aim of developing new therapies to combat human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
  • 批准号:
    10543819
  • 项目类别:
  • 资助金额:
    $85.4万
  • 财政年份:
    2019
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
  • 批准号:
    10327636
  • 项目类别:
  • 资助金额:
    $85.38万
  • 财政年份:
    2019
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
The role of CDKN2B in efferocytosis and atherosclerosis
  • 批准号:
    9247021
  • 项目类别:
  • 资助金额:
    $40.36万
  • 财政年份:
    2015
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
The paradoxical role of CDKN2B in blood vessel sprouting and maturation
  • 批准号:
    9173040
  • 项目类别:
  • 资助金额:
    $46.66万
  • 财政年份:
    2014
  • 负责人:
    Nicholas James Leeper
  • 依托单位:
海外基金